https://www.zacks.com/stock/news/2263590/centene-cnc-q1-earnings-beat-on-premiums-24-eps-view-hiked?cid=CS-ZC-FT-analyst_blog|earnings_article-2263590
Apr 26, 2024 - Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
zc:-4981006403784773772
0
https://www.zacks.com/stock/news/2262684/molina-healthcare-moh-q1-earnings-beat-on-growing-membership?cid=CS-ZC-FT-analyst_blog|earnings_article-2262684
Apr 25, 2024 - Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.
zc:23898089247037369
0
https://www.zacks.com/stock/news/2261553/humana-hum-q1-earnings-taking-a-look-at-key-metrics-versus-estimates-revised?cid=CS-ZC-FT-fundamental_analysis|nfm-2261553
Apr 24, 2024 - Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:1363789530965814030
0
https://www.zacks.com/stock/news/2261552/premium-growth-propels-humana-hum-to-easy-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2261552
Apr 24, 2024 - Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
zc:7573814041588294672
0
https://www.zacks.com/stock/news/2260440/why-earnings-season-could-be-great-for-humana-hum?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-2260440
Apr 23, 2024 - Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
zc:-1917213799915154288
0
https://www.zacks.com/stock/news/2260507/watch-these-5-medical-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260507
Apr 23, 2024 - Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
zc:-4270712098456522730
0
https://www.zacks.com/stock/news/2258552/will-humana-hum-q1-earnings-beat-on-centerwell-strength?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258552
Apr 19, 2024 - Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.
zc:4909571378020674613
0
https://www.zacks.com/stock/news/2258502/analysts-estimate-centene-cnc-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2258502
Apr 19, 2024 - Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:5307242252974664373
0
https://www.zacks.com/stock/news/2258377/what-analyst-projections-for-key-metrics-reveal-about-humana-hum-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258377
Apr 19, 2024 - Evaluate the expected performance of Humana (HUM) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zc:-5175040487450532496
0
https://www.zacks.com/stock/news/2256927/humana-hum-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2256927
Apr 17, 2024 - Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-3959694717641746823
0